Breaking News, Financial News

Financial Report: Sanofi

Revenues up 7% in the quarter

Sanofi

4Q Revenues: €9.1 billion (+7%)

4Q Earnings: €1.8 billion (+1%)

FY Revenues: €33.8 billion (+3%)

FY Earnings: €6.8 billion (+2%)

Comments: Diabetes division sales increased 11% in the quarter to €2.0 billion, driven by Lantus, up 11% to €1.8 billion. Genzyme sales grew 22% to €746 million boosted by MS drug Aubagio (€146 million, up 99%). Sanofi Pasteur sales increased 16% to €1.2 billion driven by influenza vaccines in the U.S. and Emerging Markets as well as the continued recovery of Pentacel in the U.S. Consumer Healthcare sales were €817 million in the quarter, up 14%. Animal Health sales were up 12% to €507 million driven by the launch of NexGard.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters